Collection
VPAG quarterly net sales and payment information
Information on how the voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.
This page holds quarterly aggregate net sales from:
- 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) members
- companies regulated by the Branded Health Service Medicines (Costs) Regulations 2018
It also holds information received on parallel imports.
The voluntary scheme for branded medicines pricing, access and growth (VPAG) started on 1 January 2024, replacing the voluntary scheme for branded medicines pricing and access (VPAS).